Cargando…
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
BACKGROUND: Inflammation plays an important role in the pathogenesis of ovarian cancer. This study sought to investigate the association between the preoperative c-reactive protein/albumin ratio (CRP/Alb) and oncological outcomes in ovarian cancer patients. METHODS: Two hundred patients with histolo...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399817/ https://www.ncbi.nlm.nih.gov/pubmed/28431566 http://dx.doi.org/10.1186/s12885-017-3220-x |
_version_ | 1783230711632756736 |
---|---|
author | Liu, Yubo Chen, Shengfu Zheng, Chengyu Ding, Miao Zhang, Lan Wang, Liangan Xie, Meiqing Zhou, Jianhua |
author_facet | Liu, Yubo Chen, Shengfu Zheng, Chengyu Ding, Miao Zhang, Lan Wang, Liangan Xie, Meiqing Zhou, Jianhua |
author_sort | Liu, Yubo |
collection | PubMed |
description | BACKGROUND: Inflammation plays an important role in the pathogenesis of ovarian cancer. This study sought to investigate the association between the preoperative c-reactive protein/albumin ratio (CRP/Alb) and oncological outcomes in ovarian cancer patients. METHODS: Two hundred patients with histologically verified ovarian cancer between June 2006 and July 2012 were retrospectively reviewed. Overall survival was evaluated by the Kaplan–Meier method and log-rank test. The significance of risk factors for overall survival was evaluated with the Cox proportional hazards model. Additionally, area under the receiver operating characteristic curve (AUC) was used to compare the predictive ability of CRP/Alb, Glasgow Prognostic Score (GPS), modified GPS (mGPS), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), prognostic index (PI) and prognostic nutritional index (PNI). RESULTS: The optimal cutoff value of CRP/Alb was 0.68. Increased CRP/Alb (≥0.68) was associated with advanced stage, residual tumor, ascites, elevated serum carbohydrate antigen(CA)-125 level, GPS, and mGPS (all p < 0.05). Patients with high CRP/Alb had poor overall survival compared to those with low CRP/Alb (p < 0.001). Multivariable analysis showed that CRP/Alb (Hazard Ratio (HR) 1.330, 95% confidence interval (CI) 1.131–1.564, p = 0.001), tumor stage (HR 1.577, 95% CI 1.189–2.091, p = 0.002), residual tumor (HR 2.337, 95% CI 1.518–3.597, p < 0.001) and age (HR 1.017, 95% CI 1.000–1.035, p = 0.046) were independent prognostic factors for overall survival. Additionally, the CRP/Alb showed greater AUC values at 1 year (0.692), 3 years (0.659), and 5 years (0.682) than GPS, mGPS and PNI. CONCLUSIONS: The CRP/Alb is a novel independent marker of poor prognosis among ovarian cancer patients and shows superior prognostic ability compared to the established inflammation-based prognostic indices. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3220-x) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5399817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-53998172017-04-24 The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer Liu, Yubo Chen, Shengfu Zheng, Chengyu Ding, Miao Zhang, Lan Wang, Liangan Xie, Meiqing Zhou, Jianhua BMC Cancer Research Article BACKGROUND: Inflammation plays an important role in the pathogenesis of ovarian cancer. This study sought to investigate the association between the preoperative c-reactive protein/albumin ratio (CRP/Alb) and oncological outcomes in ovarian cancer patients. METHODS: Two hundred patients with histologically verified ovarian cancer between June 2006 and July 2012 were retrospectively reviewed. Overall survival was evaluated by the Kaplan–Meier method and log-rank test. The significance of risk factors for overall survival was evaluated with the Cox proportional hazards model. Additionally, area under the receiver operating characteristic curve (AUC) was used to compare the predictive ability of CRP/Alb, Glasgow Prognostic Score (GPS), modified GPS (mGPS), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), prognostic index (PI) and prognostic nutritional index (PNI). RESULTS: The optimal cutoff value of CRP/Alb was 0.68. Increased CRP/Alb (≥0.68) was associated with advanced stage, residual tumor, ascites, elevated serum carbohydrate antigen(CA)-125 level, GPS, and mGPS (all p < 0.05). Patients with high CRP/Alb had poor overall survival compared to those with low CRP/Alb (p < 0.001). Multivariable analysis showed that CRP/Alb (Hazard Ratio (HR) 1.330, 95% confidence interval (CI) 1.131–1.564, p = 0.001), tumor stage (HR 1.577, 95% CI 1.189–2.091, p = 0.002), residual tumor (HR 2.337, 95% CI 1.518–3.597, p < 0.001) and age (HR 1.017, 95% CI 1.000–1.035, p = 0.046) were independent prognostic factors for overall survival. Additionally, the CRP/Alb showed greater AUC values at 1 year (0.692), 3 years (0.659), and 5 years (0.682) than GPS, mGPS and PNI. CONCLUSIONS: The CRP/Alb is a novel independent marker of poor prognosis among ovarian cancer patients and shows superior prognostic ability compared to the established inflammation-based prognostic indices. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3220-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-21 /pmc/articles/PMC5399817/ /pubmed/28431566 http://dx.doi.org/10.1186/s12885-017-3220-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Liu, Yubo Chen, Shengfu Zheng, Chengyu Ding, Miao Zhang, Lan Wang, Liangan Xie, Meiqing Zhou, Jianhua The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer |
title | The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer |
title_full | The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer |
title_fullStr | The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer |
title_full_unstemmed | The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer |
title_short | The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer |
title_sort | prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399817/ https://www.ncbi.nlm.nih.gov/pubmed/28431566 http://dx.doi.org/10.1186/s12885-017-3220-x |
work_keys_str_mv | AT liuyubo theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT chenshengfu theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT zhengchengyu theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT dingmiao theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT zhanglan theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT wangliangan theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT xiemeiqing theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT zhoujianhua theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT liuyubo prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT chenshengfu prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT zhengchengyu prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT dingmiao prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT zhanglan prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT wangliangan prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT xiemeiqing prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer AT zhoujianhua prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer |